Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

US PHARMACOPEIA

Filed by KYLE HOUSE GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
fd7ade24-d0dc-46d6-9fec-de6bd8113da1
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

FOR · Foreign Relations

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs. H.R. 8595, the National Security, Department of State, and Related Programs Appropriations Act, 2027

Literal federal measure citations: H.R. 8595

HCR · Health Issues

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs. H.R. 8595, the National Security, Department of State, and Related Programs Appropriations Act, 2027

Literal federal measure citations: H.R. 8595

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.